Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Non Operating Income (2016 - 2020)

Niagen Bioscience (NAGE) has disclosed Non Operating Income for 11 consecutive years, with -$12000.0 as the latest value for Q1 2020.

  • Quarterly Non Operating Income fell 134.29% to -$12000.0 in Q1 2020 from the year-ago period, while the trailing twelve-month figure was -$12000.0 through Jun 2020, down 175.0% year-over-year, with the annual reading at $125000.0 for FY2019, 186.81% up from the prior year.
  • Non Operating Income for Q1 2020 was -$12000.0 at Niagen Bioscience, down from $125000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $746000.0 in Q3 2017, with the low at -$448416.0 in Q3 2016.
  • Average Non Operating Income over 5 years is -$17051.3, with a median of -$36000.0 recorded in 2017.
  • Peak annual rise in Non Operating Income hit 266.36% in 2017, while the deepest fall reached 1891.15% in 2017.
  • Over 5 years, Non Operating Income stood at -$18360.0 in 2016, then crashed by 139.83% to -$44033.0 in 2017, then crashed by 227.03% to -$144000.0 in 2018, then skyrocketed by 186.81% to $125000.0 in 2019, then tumbled by 109.6% to -$12000.0 in 2020.
  • According to Business Quant data, Non Operating Income over the past three periods came in at -$12000.0, $125000.0, and $35000.0 for Q1 2020, Q2 2019, and Q1 2019 respectively.